NovoCure Ltd Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NovoCure Ltd quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2014 to Q3 2024.
  • NovoCure Ltd Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $31.4M, a 19% increase year-over-year.
  • NovoCure Ltd Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $115M, a 10.3% decline year-over-year.
  • NovoCure Ltd annual Share-based Payment Arrangement, Expense for 2023 was $116M, a 8.09% increase from 2022.
  • NovoCure Ltd annual Share-based Payment Arrangement, Expense for 2022 was $107M, a 12.7% increase from 2021.
  • NovoCure Ltd annual Share-based Payment Arrangement, Expense for 2021 was $94.9M, a 25.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $115M $31.4M +$5.02M +19% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $110M $31.8M -$910K -2.78% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $111M $34.1M -$5M -12.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $116M $17.4M -$12.3M -41.4% Oct 1, 2023 Dec 31, 2023 10-Q 2024-10-30
Q3 2023 $128M $26.3M +$41K +0.16% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $128M $32.7M +$6.92M +26.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 $121M $39.1M +$14M +56.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $107M $29.8M +$7.38M +33% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $99.6M $26.3M +$547K +2.12% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $99M $25.8M -$2.06M -7.38% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $101M $25M +$6.18M +32.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $94.9M $22.4M +$2.13M +10.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $92.8M $25.8M +$5.64M +28% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $87.1M $27.9M +$9.11M +48.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 $78M $18.9M +$2.31M +13.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $75.7M $20.3M +$5.58M +37.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $70.1M $20.1M +$5.78M +40.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $64.4M $18.8M +$5.04M +36.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $59.3M $16.6M +$6.91M +71.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $52.4M $14.7M +$4.06M +38.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $48.4M $14.3M +$3.86M +36.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $44.5M $13.7M +$3.53M +34.5% Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-10-02
Q1 2019 $41M $9.65M +$1.13M +13.3% Jan 1, 2019 Mar 31, 2019 10-Q/A 2020-10-02
Q4 2018 $39.8M $10.6M +$4.29M +67.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $35.6M $10.5M +$1.85M +21.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $33.7M $10.2M +$2.64M +34.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-25
Q1 2018 $31.1M $8.52M +$3.96M +86.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $27.1M $6.36M +$1.63M +34.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $25.5M $8.63M +$3M +53.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-25
Q2 2017 $22.5M $7.57M +$1.93M +34.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-26
Q1 2017 $20.5M $4.56M -$895K -16.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-26
Q4 2016 $21.4M $4.72M +$234K +5.21% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $21.2M $5.63M +$2.7M +92.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $18.5M $5.64M +$3.01M +114% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 $15.5M $5.46M +$3.64M +201% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-27
Q4 2015 $11.9M $4.49M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-22
Q3 2015 $2.93M +$1.72M +143% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $2.63M Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $1.81M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q3 2014 $1.21M Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.